Introducing Applied Clinical Trials' EDC News, a newsletter with news, articles, and information about EDC, IT, and eClinical.
Medidata Raves On EDC
Medidata's Rave EDC product has been moving in some interesting circles. In addition to becoming CDISC compliant, the products' accreditation program has been expanded so that CROs and other partners may achieve graduated levels of Rave service and support. Read about the CDISC initiatives here and about the Certification program here.
Almac Clinical Technologies
Almac Clinical Technologies provides phone and internet based interactive clinical technology solutions that improve the quality and efficiency of the clinical trial process. Our offerings include IVRS/ IXRS, iTrial EDC & ePRO.
www.almacgroup.com
eResearchTechnology
EDC Now! From eRTEDC is Evolving. eRT believes there is a better way.Visit us at DIA Booth# 800 for a demonstration!
invivodata
Clinical trial sponsors talked. We listened. Introducing the SitePRO® Tablet-the right size for site-based ePRO.
Management Forum's The CTD: An Introductory Overview
July 2, 2008
Location | London, UK
Pharmaceutical Information Management 2008
July 14–16, 2008
Location | Philadelphia, PA
CfPIE's FDA Inspections of Clinical Data Systems
July 17–18, 2008
Location | Costa Mesa, CA
Thomas Wells
- appointed OmniComm's vice president of technical operations.
Jim Walker
- of Octagon Research Solutions is a finalist in the American Business Awards.
Alan Gelenberg
- joins Healthcare Technology Systems as president, chief executive officer. (PDF)
Tim Pratt of MedNet Solutions (Minnetonka, MN) offers his comment on for-profit conferences in our industry. Click here to read more.
XClinical, a Germany-based EDC software vendor, participated in the CDISC Interchange in Japan earlier this month. Click here to read more.
Oncology-focused CRO ACORN (Memphis, TN) made its proprietary EDC system available to the clinical trials market. See the company press release here.
You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
2 Commerce Drive
Cranbury, NJ 08512